+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trial Supplies Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III), by Product & Services, by End Use, by Therapeutic Use, by Region, and Segment Forecasts, 2022-2030

  • ID: 4375410
  • Report
  • April 2022
  • Region: Global
  • 123 Pages
  • Grand View Research

FEATURED COMPANIES

  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Marken
  • Movianto (Walden Group)
The global clinical trial supplies market size is expected to reach USD 3.40 billion by 2030, registering a CAGR of 6.4% during the forecast period. This growth can be attributed to the increasing volume of clinical trial studies coupled with the growing complexity of conducting these trials. The COVID-19 pandemic has created opportunities for local manufacturers. To enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share. The clinical trial and pharmaceutical industry is anticipated to witness steady growth, which, in turn, will increase the demand for clinical trial supplies, thereby driving the market growth.



Canada and the U.S. are home to the majority of clinical trials. No language barrier is one of the major factors for the preference of this region for the majority of clinical trials, as the English language is widely spoken in this region. Major CROs and biopharmaceutical companies have their hub in this region, and with advancements in technology, the demand for efficient supplies is increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

The outbreak of COVID-19 has presented one major challenge, that is, the supply chain vertical of every company is facing limited movement across borders, with national export bans. Thus, companies are adopting various strategies to supply their products to the required destination. The shift toward Direct-to-Patient (DTP) deliveries may overcome the crisis to some extent. The FDA & EMA and regulatory bodies of China, Singapore, & Korea are focusing on DTP deliveries, as an alternative distribution method for investigational product supplies. DTP deliveries have ensured patient adherence and increased participation in clinical trials. For instance, in April 2020, Marken witnessed an increase in onboarded DTP trials in comparison with previous weeks.

Clinical Trial Supplies Market Report Highlights

  • Based on the clinical phase, the market was dominated by the phase III segment in 2021 with a revenue share of over 52.0%, owing to the presence of a large number of molecules being under phase III clinical trials.
  • Based on services, the storage and distribution segment is anticipated to witness the fastest CAGR of over 6.7% from 2022 to 2030. The rise in global biologics pipeline and temperature-sensitive drugs are expected to increase the complexities related to logistics of clinical trial supplies.
  • The Biologics segment is expected to register the fastest CAGR owing to increasing research in the field of genetics and biotechnology, such as the development of nanoparticle-based drug delivery systems.
  • In terms of therapeutic use or clinical indication, the oncology segment dominated the market with a revenue share of over 38.0%in 2021. According to the United Press International, hospitals in the U.S. are disposing of millions of cancer drug vials due to improper dosage, which is indicative of the need for appropriate supply management.
Frequently Asked Questions about the Global Clinical Trial Supplies Market

What is the estimated value of the Global Clinical Trial Supplies Market?

The Global Clinical Trial Supplies Market was estimated to be valued at $2.1 Billion in 2022.

What is the growth rate of the Global Clinical Trial Supplies Market?

The growth rate of the Global Clinical Trial Supplies Market is 6.4%, with an estimated value of $3.4 Billion by 2030.

What is the forecasted size of the Global Clinical Trial Supplies Market?

The Global Clinical Trial Supplies Market is estimated to be worth $3.4 Billion by 2030.

Who are the key companies in the Global Clinical Trial Supplies Market?

Key companies in the Global Clinical Trial Supplies Market include Almac Group, Biocair, Catalent, Inc., KLIFO, Movianto (Walden Group), PCI Pharma Services, Sharp, Thermo Fischer Scientific, Inc. and Parexel International Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Marken
  • Movianto (Walden Group)

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Phase
1.1.2 Product and Service
1.1.3 End Use
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for Primary Interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in APAC
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in Middle East & Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2. Executive Summary
2.1 Market Outlook
Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Expansion of Clinical Trial Sites
3.1.1.2 Growing R&D in Biologics and Biosimilars
3.1.1.3 Advancements in Supply Chain Technology
3.1.1.4 Increase in Comparator Sourcing
3.1.2 Market Restraint Analysis
3.1.2.1 Presence of Stringent Regulatory Policies
3.1.2.2 High Possibility of Counterfeiting Drugs
3.1.3 Penetration & Growth Prospect Mapping
3.1.4 SWOT Analysis by PESTEL
3.1.5 Industry Analysis-Porter’s
3.1.6 Clinical Trial Supplies Market: Impact of COVID-19
3.1.6.1 Supply Chain
3.1.6.2 Changing Market Trends
Chapter 4. Clinical Trial Supplies Market: Segment Analysis, by Phase, 2017-2030 (USD Million)
4.1 Definitions and Scope
4.2 Phase Market Share Analysis
4.3 Segment Dashboard
4.4 Clinical trial supplies Market by Phase
4.4.1 Phase I
4.4.1.1 Phase I Market Estimates and Forecast, 2017-2030 (In Million)
4.4.2 Phase II
4.4.2.1 Phase II Market Estimates and Forecast, 2017-2030 (In Million)
4.4.3 Phase III
4.4.3.1 Phase III Market Estimates and Forecast, 2017-2030 (In Million)
4.4.4 Others
4.4.4.1 Others Market Estimates and Forecast, 2017-2030 (In Million)
Chapter 5. Clinical Trial Supplies Market: Segment Analysis, by Product and Service, 2017-2030 (USD Million)
5.1 Definitions and Scope
5.2 Product and Service Market Share Analysis
5.3 Segment Dashboard
5.4 Clinical Trial Supplies Market by Product & Service
5.4.1 Manufacturing
5.4.1.1 Manufacturing Market Estimates and Forecast, 2017-2030 (In Million)
5.4.2 Storage & Distribution
5.4.2.1 Storage & Distribution Market Estimates and Forecast, 2017-2030 (In Million)
5.4.2.2 Cold Chain Distribution
5.4.2.3 Non-Cold Chain Distribution
5.4.3 Supply Chain Management
5.4.3.1 Supply Chain Management Market Estimates and Forecast, 2017-2030 (In Million)
Chapter 6. Clinical Trial Supplies Market: Segment Analysis, by End Use, 2017-2030 (USD Million)
6.1 Definitions and Scope
6.2 End-Use Market Share Analysis
6.3 Segment Dashboard
6.4 Clinical Trial Supplies Market by End Use
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates and Forecast, 2017-2030 (In Million)
6.4.2 Biologics
6.4.2.1 Biologics Market Estimates and Forecast, 2017-2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates and Forecast, 2017-2030 (In Million)
6.4.4 Others
6.4.4.1 Others Market Estimates and Forecast, 2017-2030 (In Million)
Chapter 7. Clinical Trial Supplies Market: Segment Analysis, by Therapeutic Use, 2017-2030 (USD Million)
7.1 Definitions and Scope
7.2 Therapeutic Use Market Share Analysis
7.3 Segment Dashboard
7.4 Clinical Trial Supplies Market by Therapeutic Use
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates and Forecast, 2017-2030 (In Million)
7.4.2 Central Nervous System (CNS) Disorders
7.4.2.1 CNS Market Estimates and Forecast, 2017-2030 (In Million)
7.4.3 Cardiovascular
7.4.3.1 Cardiovascular Market Estimates and Forecast, 2017-2030 (In Million)
7.4.4 Infectious diseases
7.4.4.1 Infectious Diseases Market Estimates and Forecast, 2017-2030 (In Million)
7.4.5 Metabolic disorders
7.4.5.1 Metabolic Disorders Market Estimates and Forecast, 2017-2030 (In Million)
7.4.6 Others
7.4.6.1 Others Market Estimates and Forecast, 2017-2030 (In Million)
Chapter 8. Clinical Trial Supplies Market: Regional Market Analysis, 2017-2030 (USD Million)
8.1 Regional Market Dashboard
8.2 Definitions and Scope
8.3 Regional Market Share Analysis
8.4 North America
8.4.1 North America Market Estimates and Forecast, 2017-2030
8.4.2 U.S.
8.4.2.1 U.S. Market Estimates and Forecast, 2017-2030
8.4.3 Canada
8.4.3.1 Canada Market Estimates and Forecast, 2017-2030
8.5 Europe
8.5.1 Europe Market Estimates and Forecast, 2017-2030
8.5.2 Germany
8.5.2.1 Germany Market Estimates and Forecast, 2017-2030
8.5.3 U.K.
8.5.3.1 U.K. Market Estimates and Forecast, 2017-2030
8.6 Asia Pacific
8.6.1 Asia Pacific Market Estimates and Forecast, 2017-2030
8.6.2 China
8.6.2.1 China Market Estimates and Forecast, 2017-2030
8.6.3 Japan
8.6.3.1 Japan Market Estimates and Forecast, 2017-2030
8.7 Latin America
8.7.1 Latin America Market Estimates and Forecast, 2017-2030
8.7.2 Brazil
8.7.2.1 Brazil Market Estimates and Forecast, 2017-2030
8.7.3 Mexico
8.7.3.1 Mexico Market Estimates and Forecast, 2017-2030
8.8 Middle East and Africa
8.8.1 Middle East & Africa Market Estimates and Forecast, 2017-2030
8.8.2 South Africa
8.8.2.1 South Africa Market Estimates and Forecast, 2017-2030
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Market Estimates and Forecast, 2017-2030
Chapter 9. Clinical Trial Supplies Market - Competitive Analysis
9.1 Company Profiles
9.1.1 Almac Group
9.1.1.1 Company Overview
9.1.1.2 Service Benchmarking
9.1.1.3 Strategic Initiatives
9.1.2 Biocair
9.1.2.1 Company Overview
9.1.2.2 Service Benchmarking
9.1.2.3 Strategic Initiatives
9.1.3 Catalent, Inc.
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Service Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 KLIFO
9.1.4.1 Company Overview
9.1.4.2 Service Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5 Movianto (Walden Group)
9.1.5.1 Company Overview
9.1.5.2 Service Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6 PCI Pharma Services
9.1.6.1 Company Overview
9.1.6.2 Service Benchmarking
9.1.6.3 Strategic Initiatives
9.1.7 Sharp
9.1.7.1 Company Overview
9.1.7.2 Service Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8 Thermo Fischer Scientific, Inc.
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Service Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 MARKEN
9.1.9.1 Company Overview
9.1.9.2 Service Benchmarking
9.1.9.3 Strategic Initiatives
9.1.10 PAREXEL INTERNATIONAL CORPORATION
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Service Benchmarking
9.1.10.4 Strategic Initiatives
Note: Product cover images may vary from those shown
  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Movianto (Walden Group)
  • PCI Pharma Services
  • Sharp
  • Thermo Fischer Scientific, Inc.
  • Marken
  • Parexel International Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...